Search This Blog

Wednesday, January 25, 2023

Intercept Pharmaceuticals Unit On Jan 24 Entered Into Settlement Agreement With Amneal

 

Granted Amneal Non-exclusive, Non-Sublicensable, Non-Transferable, Royalty-free License To Commercialize Generic Version

https://www.benzinga.com/general/biotech/23/01/30566234/intercept-pharmaceuticals-unit-on-jan-24-entered-into-settlement-agreement-with-amneal-eu-limited

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)